Elsevier

Journal of Psychiatric Research

Volume 28, Issue 5, September–October 1994, Pages 461-473
Journal of Psychiatric Research

Acute antagonism of dopamine D2-like receptors by amisulpride: Effects on hormone secretion in healthy volunteers

https://doi.org/10.1016/0022-3956(94)90004-3Get rights and content

Abstract

Amisulpride is a selective D2-like dopamine receptor antagonist with a high affinity for the cloned D2 and D3 receptors. At low doses it may improve depressive and negative schizophrenic symptoms whereas antipsychotic effects on positive schizophrenic symptomatology require higher dosages. Acute endocrine effects were studied for two doses of amisulpride with regard to the daytime secretion of prolactin, thyroidea stimulating hormone (TSH), growth hormone (GH), luteinizing hormone (LH) and cortisol. Amisulpride was administered i.v. to eight healthy male volunteers in a single-blind trial under a randomized cross-over, placebo-controlled design using doses of 20 mg or 100 mg, or saline. The drug was injected at 09:00 h, and plasma samples were withdrawn from 08:30 h to 16:00 h at intervals of 15 and 30 min, respectively. At both dosages, prolactin was significantly elevated to the eight- to ten-fold of baseline levels. Likewise, a significant 50% elevation of TSH concentrations with a trend to a greater increase under the 100 mg dose was observed. Plasma levels of LH and cortisol were not significantly affected by amisulpride. With regard to GH secretion, there was a trend to a decrease only with the 20 mg dose. These results indicate that the neuroendocrinological side-effect profile of acute amisulpride administration may be similar to conventional neuroleptics, and that there are only minor dose-dependent differential effects on hormone secretion in the dose range investigated.

References (39)

  • B. Landwehrmeyer et al.

    Dopamine D3 receptor mRNA and binding sites in human brain

    Brain Research and Molecular Brain Research

    (1993)
  • D.R. Sibley et al.

    Molecular biology of dopamine receptors

    Trends in Pharmacological Sciences

    (1992)
  • L.A. Snyder et al.

    Distribution of dopamine D2 receptor mRNA splice variants in the rat by solution hybridization/protection assay

    Neuroscience Letters

    (1991)
  • A.B. Abou-Samra et al.

    Acute dopaminergic blockade by sulpiride stimulates β-endorphin secretion in pregnant women

    Clinical Endocrinology

    (1984)
  • O. Benkert et al.

    Missing indicator function of growth hormone and luteinizing hormone blood levels for dopamine and serotonin concentration in the human brain

    Journal of Neural Transmission

    (1973)
  • E.G. Brabant et al.

    Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration

    Journal of Clinical Endocrinology and Metabolism

    (1987)
  • B.A. Coche et al.

    Place de l'amisulpride dans le groupe des benzamides substitués

    Actualités Psychiatriques

    (1986)
  • C. Dieguez et al.

    L-Dopa releases GH via GRF dependent mechanism in normal human subjects, whereas arginine, clonidine and adrenaline plus propanolol do not

  • G. Delitela et al.

    Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man

    Neuroendocrinology

    (1987)
  • E.C. Drobny et al.

    Circadian rhythm of basal growth hormone in man

    Journal of Clinical Endocrinology and Metabolism

    (1983)
  • A. Dufour et al.

    Pharmacocinétique et métabolisme de l'amisulpride

    Annales de Psychiatrie

    (1988)
  • F. Duval et al.

    Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new anti-psychotic drugs, in schizophrenic patients

    Psychopharmacology

    (1993)
  • S.M. Foord et al.

    Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin

    Endocrinology

    (1983)
  • R.V. Gallo

    Further studies on dopamine-induced suppression of pulsatile LH release in ovariectomized rats

    Neuroendocrinology

    (1981)
  • F. Gekière et al.

    Biological tolerance of amisulpride with long-term treatment

  • J.W. Gunnet et al.

    Neuroleptics and neuroendocrine function

    Annual Review of Pharmacology and Toxicology

    (1988)
  • C. Hiemke et al.

    Effects of oestradiol benzoate and progesterone on luteinizing hormone release and catecholamine turnover in the preoptic-hypothalamic brain area of of ovariectomized rats

    Journal of Endocrinology

    (1983)
  • D.M. Jacobowitz

    Multifactorial control of pituitary hormone secretion: the “wheels” of the brain

    Synapse

    (1988)
  • P. Jenner et al.

    Multiple dopamine receptors in brain and the pharmacological action of substituted benzamides

    Acta Psychiatrica Scandinavica

    (1984)
  • Cited by (58)

    • Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis

      2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Similarly, a large retrospective cohort study demonstrated that acute treatment with quetiapine is strongly associated with the development of new-onset hypothyroidism (Zhao et al., 2021). Other studies have shown that phenothiazine and amisulpride may increase the levels of TSH after stimulation by thyrotropin-releasing hormone (TRH) (Gründer et al., 1999; Khalil and Richa, 2011; Wetzel et al., 1994; Zatelli et al., 2014). In turn, clozapine has been found to decrease TRH-stimulated level of TSH (Paunovlć et al., 1991).

    • Effects of antipsychotics on circadian rhythms in humans: a systematic review and meta-analysis

      2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Five of these studies used atypical AP. In contrast, another five RCTs with 112 individuals on AP and 69 with no AP reported no difference in cortisol levels as measured from plasma, saliva or urine between individuals on AP and placebo (Cohrs et al., 2006; de Koning and de Vries, 1995; Handley et al., 2016; von Bahr et al., 1991; Wetzel et al., 1994). Among these five articles, four RCTs used atypical AP (de Koning and de Vries, 1995, Handley et al., 2016, von Bahr et al., 1991, Wetzel et al., 1994).

    • Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication

      2018, Journal of Psychiatric Research
      Citation Excerpt :

      Of second-generation drugs, mainly amisulpride, quetiapine and clozapine have been studied regarding thyroid function (Bou Khalil and Richa, 2011). Use of quetiapine has been linked to cases of hypothyroidism (Feret and Caley, 2000; Kontaxakis et al., 2009), amisulpride to elevated TRH-stimulated TSH (Grunder et al., 1999; Wetzel et al., 1994) whereas clozapine has been associated with reduced TRH-stimulated TSH concentration (Paunovic et al., 1991). Also aripiprazole has been linked to thyroid abnormalities in combinations with olanzapine (Ohta et al., 2017) and sertraline (Church and Callen, 2009).

    • Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers

      2016, Schizophrenia Research
      Citation Excerpt :

      Amongst other unique pharmacological properties that separate aripiprazole from other SGAs, this drug has a lower affinity for 5HT-2 than for D2 receptors (Mamo et al., 2007). It is interesting to note that amisulpride, the only SGA that has a similarly lower affinity for 5HT-2 than D2 receptors, has also been associated with an absence of effect on cortisol in healthy individuals (Wetzel et al., 1994), suggesting that the dopamine-serotonin affinity profile common to these drugs, and not other SGAs, might be important in HPA axis regulation. Together with the haloperidol effects evident in our study, this indicates that it is not only the affinity to dopamine receptors that is key in the regulation of stress and pro-inflammatory markers, but also the function of that drug on dopamine receptors (i.e. antagonistic vs partial agonism).

    • Amisulpride-induced hyperprolactinemia is reversible following discontinuation

      2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    View all citing articles on Scopus
    View full text